Search
Home
Business
Tech
Education
Interviews and Features
Others
Books
CSR
Environment
Entertainment
Health and Wellness
Finance
Hospitality
International
Lifestyle
Sports
Startup
Travel
Webnewswire
Leading newswire service
Home
Business
Tech
Education
Interviews and Features
Others
Books
CSR
Environment
Entertainment
Health and Wellness
Finance
Hospitality
International
Lifestyle
Sports
Startup
Travel
Home
Tags
Biogen
Tag: Biogen
Business
Japan – Eisai and Biogen Announce U.S. Availability of LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease
Correspondent
-
October 9, 2025
0
Business
Japan – Biogen Japan and Eisai Provide Update on Co-Promotion Of Multiple Sclerosis Treatments In Japan
-
March 3, 2023
0
Business
Japan – Biogen and Eisai Amend Collaboration Agreements on Alzheimer’s Disease Treatments
-
March 15, 2022
0
Business
Biogen Announces Reduced Price for Aduhelm to Improve Access For Patients With Early Alzheimer’s Disease In The United States
-
December 21, 2021
0
Uncategorized
Eisai and Biogen Present Preliminary Assessment of the Clinical Effects of Lecanemab (BAN2401)
-
July 30, 2021
0
Uncategorized
Japan – Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer’s Disease at AAIC 2021
-
July 30, 2021
0
Uncategorized
Japan – Biogen and Eisai Announce ADUHELMTM (aducanumab-avwa) Data Presentations at Alzheimer’s Association International Conference 2021
-
July 27, 2021
0
Uncategorized
Eisai and Biogen Inc. Announce U.S. FDA Grants Breakthough Therapy Designation for Lecanemab (BAN2401)
-
June 24, 2021
0
